Thromboprophylaxis after orthopaedic surgery
نویسندگان
چکیده
منابع مشابه
Orthopaedic surgeons and thromboprophylaxis.
OBJECTIVE To assess attitudes to the use of thromboprophylaxis among orthopaedic surgeons in the United Kingdom. DESIGN AND SUBJECTS Single page postal questionnaire to all 926 active orthopaedic surgeons who are members of the British Orthopaedic Association. RESULTS The response rate was 70% (659 surgeons), of whom 595 (90%) used some form of prophylaxis. Most (548; 83%) used drugs but 47...
متن کاملThromboprophylaxis and orthopaedic surgery: options and current guidelines.
Antithrombotic therapy remains crucial in the peri- and post-operative management of patients who undergo orthopaedic surgical procedures, particularly total joint arthroplasty (TJA) and hip fracture surgery (HFS). Optimal thromboprophylaxis is currently mandatory in most orthopaedic practices to avoid the dreaded complications of venous thromboembolism (VTE). The pathogenesis of VTE is multifa...
متن کاملSimplifying Thromboprophylaxis Could Improve Outcomes in Orthopaedic Surgery
Venous thromboembolism is a serious complication after total hip or knee surgery, and there is a well-established clinical need for thromboprophylaxis. However, in a large number of cases adequate administration of thromboprophylaxis does not seem to occur after total joint arthroplasty. A major challenge in the management of thromboprophylaxis is to balance the benefits of treatment with the r...
متن کاملBleeding complications after systematic switch of routine thromboprophylaxis for major orthopaedic surgery.
The rate of bleeding complications after major orthopedic surgery approximates 2%. It is unclear whether a systematic switch of routine thromboprophylaxis has an impact on the rate of postoperative bleeding complications. We analyzed prospectively recorded postoperative bleeding complications and symptomatic venous thromboembolic events in 8,176 consecutive orthopedic patients at the Schulthess...
متن کاملRivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co‐medication interactions
AIM The aim of the present study was to analyse concomitant drug use and its association with outcome in patients (N = 17 701) receiving rivaroxaban or standard of care (SOC) for the prevention of venous thromboembolism after major orthopaedic surgery in the non-interventional, phase IV XAMOS (Xarelto® in the prophylaxis of post-surgical venous thromboembolism after elective major orthopaedic s...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Klinická farmakologie a farmacie
سال: 2018
ISSN: 1212-7973,1803-5353
DOI: 10.36290/far.2017.022